Human iPSC From Fibroblast-Epidermolysis Bullosa
HighQC™ Human iPSC From Fibroblast-Epidermolysis Bullosa offers patient-derived models for dystrophic, junctional, and simplex type EB disease studies.
本分类收录的细胞产品与配套技术资料,支持按来源、物种与规格筛选。 共 293 个产品。
HighQC™ Human iPSC From Fibroblast-Epidermolysis Bullosa offers patient-derived models for dystrophic, junctional, and simplex type EB disease studies.
Human iPSC From Fibroblast-FOP enables modeling of fibrodysplasia ossificans progressiva and related bone disorders in pluripotent stem cells.
Human iPSC From Fibroblast-GLUT1 Deficiency Syndrome 1 offers a patient-specific model for studying glucose transporter defects and therapies.
Human iPSC From Fibroblast-Glycogen Storage Disease II ,Fibroblast-derived iPSCs for Glycogen Storage Disease II (Pompe) research and therapeutic studies.
Human iPSC From Fibroblast-Hurler Syndrome ,Patient-derived iPSC line for Hurler Syndrome, supporting IDUA deficiency, lysosomal storage research.
Human iPSC From Fibroblast-Isogenic Control Congenital Disorder Of Deglycosylation ,Fibroblast iPSCs for CDDG, NGLY1, glycosylation and therapy studies.
Human iPSC From Fibroblast-Isogenic Control GLUT1 Deficiency Syndrome 1 ,iPSC for modeling GLUT1DS1 and studying glucose transport and metabolic disorders.
HighQC™ Human iPSC From Fibroblast-Isogenic Control, Congenital Disorder Of Deglycosylation provides reliable disease-specific models for CDDG studies.
Fibroblast-derived iPSC isogenic control for cystic fibrosis supports CFTR studies, disease modeling, drug testing, and personalized medicine research.
Human iPSC From Fibroblast-Isogenic Control provides iPSCs for disease modeling, drug discovery, and regenerative medicine research applications.
Human iPSC From Fibroblast-Isogenic Control, LQTS2 model for cardiac electrophysiology, ion channel research, and personalized therapy development.
Human iPSC From Fibroblast-Isogenic Control, Rett Syndrome, Congenital Variant offers matched genetic controls for neurological and therapeutic studies.
Human iPSC From Fibroblast-Isogenic Control, Tay-Sachs Disease for modeling neurodegeneration, GM2 gangliosidosis, and lysosomal storage diseases.
Human iPSC From Fibroblast-Isogenic Control, Vici Syndrome provides a model for gene therapy and Vici syndrome research in cellular and genetic studies.
Human iPSC From Fibroblast-Leigh Syndrome provides a disease-relevant iPSC model for mitochondrial dysfunction, energy metabolism, and drug discovery.
Human iPSC From Fibroblast-Long QT Syndrome 3 ,iPSCs derived from LQT3 fibroblasts for cardiac arrhythmia, ion channel dysfunction, and disease modeling.
Human iPSC From Fibroblast-Maturity Onset Diabetes ,Fibroblast-derived iPSCs for maturity onset diabetes research, disease modeling, and therapy studies.
Human iPSC From Fibroblast-Mental Retardation ,iPSC model for autosomal dominant MRD40 studies, CHAMP1 biology, neurodevelopment, and disease mechanisms.
The Human iPSC From Fibroblast-Miller-Dieker Lissencephaly Syndrome provides a model for neuronal studies, genetic analysis, and drug research.
Assess Human iPSC From Fibroblast-Mucopolysaccharidosis Type II, high-quality iPSC line for studying IDS function and MPS II disease modeling.
Human iPSC From Fibroblast-Mucopolysaccharidosis Type IVA offers a disease-specific iPSC model for MPS IVA-related developmental and drug research.
Human iPSC From Fibroblast-Dystroglycanopathy Type B enables disease modeling, drug screening, and therapeutic research in muscular dystrophy.
Human iPSC From Fibroblast-Muscular Dystrophy, Becker Type delivers disease-relevant iPSCs for muscular dystrophy modeling and drug discovery.
Human iPSC From Fibroblast-Neuroaxonal Dystrophy provides a disease-specific model for neurodegeneration, axonal pathology, and therapeutic screening.
共 293 个产品 | 第 11 / 13 页